title: Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
abstract: The 2001/2008 World Health Organization (WHO)-based diagnostic criteria for polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) were recently revised to accomodate new information on disease-specific mutations and underscore distinguishing morphologic features. In this context, it seems to be reasonable to compare first major diagnostic criteria of the former WHO classifications for myeloproliferative neoplasm (MPN) and then to focus on details that have been discussed and will be proposed for the upcoming revision of diagnostic guidelines. In PV, a characteristic bone marrow (BM) morphology was added as one of three major diagnostic criteria, which allowed lowering of the hemoglobin/hematocrit threshold for diagnosis, which is another major criterion, to 16.5 g/dl/49% in men and 16 g/dl/48% in women. The presence of a JAK2 mutation remains the third major diagnostic criterion in PV. Subnormal serum erythropoietin level is now the only minor criterion in PV and is used to capture JAK2-unmutated cases. In ET and PMF, mutations that are considered to confirm clonality and specific diagnosis now include CALR, in addition to JAK2 and MPL. Also in the 2015 discussed revision, overtly fibrotic PMF is clearly distinguished from early/prefibrotic PMF and each PMF variant now includes a separate list of diagnostic criteria. The main rationale for these changes was to enhance the distinction between so-called masked PV and JAK2-mutated ET and between ET and prefibrotic early PMF. The proposed changes also underscore the complementary role, as well as limitations of mutation analysis in morphologic diagnosis. On the other hand, discovery of new biological markers may probably be expected in the future to enhance discrimination of the different MPN subtypes in accordance with the histological BM patterns and corresponding clinical features.
authors.affiliation: Hematology and Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.affiliation: Institute of Pathology, University of Cologne, Cologne, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Thiele
authors.affiliation: Department of Experimental and Clinical Medicine, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.affiliation: Hematology Division, Mayo Clinic, Rochester, MN, USA.
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D001853:Bone Marrow / Q000473:pathology; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D009154:Mutation; D011087:Polycythemia Vera / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D017410:Practice Guidelines as Topic; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D013920:Thrombocythemia, Essential / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D014944:World Health Organization
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2
references.citation: Blood. 2010 Aug 12;116(6):988-92
references.pmid: 20404132
references.citation: Leukemia. 2010 Sep;24(9):1574-9
references.pmid: 20631743
references.citation: Blood. 2011 May 26;117(21):5710-8
references.pmid: 21447832
references.citation: Am J Hematol. 2011 Aug;86(8):701-2
references.pmid: 21674576
references.citation: J Clin Oncol. 2011 Aug 10;29(23):3179-84
references.pmid: 21747083
references.citation: Am J Clin Pathol. 2011 Oct;136(4):618-24
references.pmid: 21917685
references.citation: Haematologica. 2012 Mar;97(3):360-5
references.pmid: 22058215
references.citation: Histol Histopathol. 2005 Jan;20(1):317-28
references.pmid: 15578448
references.citation: Histol Histopathol. 2005 Apr;20(2):633-44
references.pmid: 15736066
references.citation: Acta Haematol. 2005;113(2):137-43
references.pmid: 15802893
references.citation: Nature. 2005 Apr 28;434(7037):1144-8
references.pmid: 15793561
references.citation: Curr Hematol Rep. 2005 May;4(3):213-7
references.pmid: 15865874
references.citation: Br J Haematol. 2005 Jun;129(5):701-5
references.pmid: 15916693
references.citation: Acta Haematol. 2005;113(4):213-9
references.pmid: 15983426
references.citation: Am J Hematol. 2014 Feb;89(2):199-202
references.pmid: 24166817
references.citation: Am J Hematol. 2014 Jun;89(6):588-90
references.pmid: 24535932
references.citation: Mod Pathol. 2014 Jun;27(6):814-22
references.pmid: 24201120
references.citation: Leukemia. 2014 Jul;28(7):1472-7
references.pmid: 24402162
references.citation: Leukemia. 2014 Jul;28(7):1407-13
references.pmid: 24441292
references.citation: Am J Hematol. 2014 Aug;89(8):E121-4
references.pmid: 24753125
references.citation: Am J Hematol. 2014 Sep;89(9):915-25
references.pmid: 25124313
references.citation: Br J Haematol. 2014 Sep;166(6):911-9
references.pmid: 24957246
references.citation: Leukemia. 2014 Sep;28(9):1804-10
references.pmid: 24549259
references.citation: Best Pract Res Clin Haematol. 2014 Jun;27(2):129-40
references.pmid: 25189724
references.citation: Leukemia. 2014 Oct;28(10):2092-4
references.pmid: 24888272
references.citation: Blood. 2014 Oct 9;124(15):2465-6
references.pmid: 25301336
references.citation: Br J Haematol. 2014 Nov;167(3):421-3
references.pmid: 24935860
references.citation: Blood. 2014 Oct 16;124(16):2507-13; quiz 2615
references.pmid: 25037629
references.citation: Blood. 2014 Oct 16;124(16):2611-2
references.pmid: 25323688
references.citation: Br J Haematol. 2014 Nov;167(4):541-6
references.pmid: 25130523
references.citation: Mod Pathol. 2014 Nov;27(11):1447-54
references.pmid: 24762543
references.citation: Nat Med. 2014 Dec;20(12):1472-8
references.pmid: 25326804
references.citation: Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10
references.pmid: 25516983
references.citation: Blood. 2014 Dec 18;124(26):3964-6
references.pmid: 25305205
references.citation: N Engl J Med. 2014 Dec 25;371(26):2488-98
references.pmid: 25426837
references.citation: N Engl J Med. 2014 Dec 25;371(26):2477-87
references.pmid: 25426838
references.citation: Leukemia. 2015 Jan;29(1):241-4
references.pmid: 25183285
references.citation: Blood. 2015 Jan 8;125(2):327-35
references.pmid: 25281607
references.citation: Pathol Annu. 1979;14 Pt 1:383-403
references.pmid: 390480
references.citation: Leukemia. 2014 Feb;28(2):431-3
references.pmid: 24097336
references.citation: J Clin Oncol. 1999 Sep;17(9):2954-70
references.pmid: 10561375
references.citation: Haematologica. 2000 May;85(5):492-5
references.pmid: 10800165
references.citation: Blood. 2002 Dec 15;100(13):4272-90
references.pmid: 12393615
references.citation: Histol Histopathol. 2003 Jan;18(1):93-102
references.pmid: 12507288
references.citation: Am J Clin Pathol. 2003 Jan;119(1):152-8
references.pmid: 12520711
references.citation: Leuk Lymphoma. 2003 Jun;44(6):949-53
references.pmid: 12854892
references.citation: N Engl J Med. 2004 Mar 18;350(12):1211-9
references.pmid: 15028825
references.citation: Haematologica. 2004 Aug;89(8):911-9
references.pmid: 15339673
references.citation: Semin Hematol. 1986 Apr;23(2):144-55
references.pmid: 3704666
references.citation: Pathol Res Pract. 1993 Mar;189(2):121-32
references.pmid: 8321741
references.citation: Leuk Lymphoma. 1996 Sep;22 Suppl 1:15-29
references.pmid: 8951769
references.citation: Semin Hematol. 1997 Jan;34(1):29-39
references.pmid: 9025160
references.citation: Am J Hematol. 1997 Nov;56(3):168-72
references.pmid: 9371529
references.citation: Br J Haematol. 1998 Jan;100(1):15-23
references.pmid: 9450785
references.citation: J Intern Med. 1999 Mar;245(3):295-300
references.pmid: 10205592
references.citation: Mayo Clin Proc. 2005 Jul;80(7):923-36
references.pmid: 16007898
references.citation: Br J Haematol. 2005 Jul;130(2):174-95
references.pmid: 16029446
references.citation: Blood. 2005 Aug 15;106(4):1207-9
references.pmid: 15860661
references.citation: Haematologica. 2005 Aug;90(8):1128-32
references.pmid: 16079113
references.citation: Br J Haematol. 2005 Oct;131(2):166-71
references.pmid: 16197445
references.citation: Cancer. 2006 Feb 1;106(3):631-5
references.pmid: 16369984
references.citation: Ann Hematol. 2006 Apr;85(4):226-32
references.pmid: 16421727
references.citation: Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):362-71
references.pmid: 16810612
references.citation: Leuk Lymphoma. 2006 Sep;47(9):1774-81
references.pmid: 17064987
references.citation: N Engl J Med. 2015 Feb 12;372(7):601-12
references.pmid: 25671252
references.citation: PLoS Med. 2006 Jul;3(7):e270
references.pmid: 16834459
references.citation: N Engl J Med. 2007 Feb 1;356(5):459-68
references.pmid: 17267906
references.citation: Blood. 2007 Aug 15;110(4):1092-7
references.pmid: 17488875
references.citation: Leukemia. 2007 Sep;21(9):1960-3
references.pmid: 17597810
references.citation: Leukemia. 2008 Feb;22(2):452-3
references.pmid: 17713549
references.citation: Leukemia. 2008 Apr;22(4):756-61
references.pmid: 18216871
references.citation: Blood. 2008 Jul 15;112(2):231-9
references.pmid: 18401028
references.citation: Am J Clin Pathol. 2008 Sep;130(3):336-42
references.pmid: 18701405
references.citation: J Clin Oncol. 2009 Jun 20;27(18):2991-9
references.pmid: 19364963
references.citation: Blood. 2009 Jul 30;114(5):937-51
references.pmid: 19357394
references.citation: Blood. 2009 Aug 20;114(8):1477-83
references.pmid: 19549988
references.citation: Exp Hematol. 2009 Oct;37(10):1186-1193.e7
references.pmid: 19616600
references.citation: Am J Hematol. 2010 Jan;85(1):62-9
references.pmid: 19844986
references.citation: Curr Hematol Malig Rep. 2009 Jan;4(1):33-40
references.pmid: 20425436
references.citation: Br J Haematol. 2010 May;149(3):352-75
references.pmid: 20331456
references.citation: Leukemia. 2010 Jun;24(6):1128-38
references.pmid: 20428194
references.citation: Histopathology. 2010 May;56(6):758-67
references.pmid: 20546341
references.citation: Blood. 2012 Mar 8;119(10):2239-41
references.pmid: 22246040
references.citation: Leukemia. 2012 Apr;26(4):716-9
references.pmid: 21926959
references.citation: PLoS One. 2012;7(4):e35631
references.pmid: 22536419
references.citation: Haematologica. 2012 Nov;97(11):1704-7
references.pmid: 22689671
references.citation: Hematology. 2013 Jan;18(1):8-13
references.pmid: 22990042
references.citation: Blood. 2013 Mar 7;121(10):1720-8
references.pmid: 23315161
references.citation: Leukemia. 2013 Sep;27(9):1861-9
references.pmid: 23619563
references.citation: Leukemia. 2013 Sep;27(9):1874-81
references.pmid: 23739289
references.citation: Blood. 2013 Sep 12;122(11):1881-6
references.pmid: 23900239
references.citation: Leukemia. 2013 Oct;27(10):1953-8
references.pmid: 23467025
references.citation: Leukemia. 2013 Oct;27(10):2100-2
references.pmid: 23558523
references.citation: Am J Hematol. 2013 Dec;88(12):1012-6
references.pmid: 23897670
references.citation: Haematologica. 2013 Dec;98(12):1872-6
references.pmid: 24056820
references.citation: N Engl J Med. 2013 Dec 19;369(25):2379-90
references.pmid: 24325356
references.citation: N Engl J Med. 2013 Dec 19;369(25):2391-405
references.pmid: 24325359
references.citation: Am J Hematol. 2014 Jan;89(1):52-4
references.pmid: 23996471